TRDA Competitors & Alternatives
Compare Entrada Therapeutics Inc with similar stocks in the same industry
Biotechnology
TRDA
Main Stock$6.92
Tradestie Score
49
Market Cap
$223.66M
Revenue Growth
-1.0%
Analyst Upside
+171.0%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$15.19
|
$308.74M | - | 60 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.49
|
$304.12M | - | 58 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$20.95
|
$297.23M | - | 59 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$34.37
|
$293.03M | - | 61 | Compare |
|
OMER
Omeros Corporation
|
$10.28
|
$281.75M | 9.0 | 57 | Compare |
|
DBVT
DBV Technologies S.A.
|
$16.49
|
$275.54M | - | 56 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.00
|
$275.13M | - | 51 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$19.14
|
$269.08M | - | 59 | Compare |
|
ZURA
Zura Bio Limited Class A Ordinary Shares
|
$5.11
|
$262.67M | - | 61 | Compare |
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$8.49
|
$258.18M | - | 59 | Compare |
More TRDA Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry